Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
198.91
-1.45 (-0.72%)
At close: Jul 9, 2026, 4:00 PM EDT
198.90
-0.01 (-0.01%)
After-hours: Jul 9, 2026, 7:59 PM EDT
| Period Ending | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Multiple Sclerosis | 4.04B | 4.04B | 4.19B | 4.18B | 4.23B | 4.35B | 4.45B | 4.55B | |||||||||||||||
| Multiple Sclerosis Growth | -4.34% | -7.14% | -5.76% | -8.10% | -8.37% | -6.70% | -6.60% | -7.90% | |||||||||||||||
| Other | 2.79B | 2.77B | 2.73B | 2.74B | 2.59B | 2.46B | 2.39B | 2.42B | |||||||||||||||
| Other Growth | 7.87% | 12.53% | 14.22% | 13.22% | 4.90% | -4.87% | -10.48% | -2.92% | |||||||||||||||
| Rare Disease | 2.15B | 2.15B | 2.17B | 2.14B | 2.13B | 1.99B | 1.87B | 1.82B | |||||||||||||||
| Rare Disease Growth | 0.98% | 8.37% | 16.58% | 17.34% | 23.36% | 13.99% | 4.21% | 2.78% | |||||||||||||||
| Biosimilars | 730.50M | 729.10M | 761.30M | 761.10M | 777.50M | 793.60M | 779.80M | 777.50M | |||||||||||||||
| Biosimilars Growth | -6.05% | -8.13% | -2.37% | -2.11% | 0.39% | 3.06% | 3.07% | 3.68% |
| Period Ending | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | 3.63B | 3.55B | 3.46B | 3.34B | 3.25B | 3.24B | 3.25B | 3.23B | |||||||||||||||
| United States Growth | 11.97% | 9.59% | 6.39% | 3.33% | 1.85% | 3.05% | 3.53% | 0.92% | |||||||||||||||
| International | 3.51B | 3.57B | 3.82B | 3.87B | 3.98B | 3.98B | 3.96B | 4.02B | |||||||||||||||
| International Growth | -11.83% | -10.18% | -3.44% | -3.72% | -0.65% | -3.14% | -5.18% | -6.11% | |||||||||||||||
| Other | 2.79B | 2.77B | 2.73B | 2.74B | 2.59B | 2.46B | 2.39B | 2.42B | |||||||||||||||
| Other Growth | 7.87% | 12.53% | 14.22% | 13.22% | 4.90% | -4.87% | -10.48% | -2.92% | |||||||||||||||
| Other Geographic | - | - | 2.73B | 2.74B | 2.59B | 2.46B | 2.39B | 2.42B | 2.47B | 2.59B | |||||||||||||
| Other Geographic Growth | - | - | 14.22% | 13.22% | 4.90% | -4.87% | -10.48% | -2.92% | 1.98% | 18.45% |